NCT05489783View on ClinicalTrials.gov

Glioma Developmental and HyperActive Ras Tumor (DHART) Board

RecruitingOBSERVATIONAL
Enrollment

50

Participants

Timeline

Start Date

July 29, 2022

Primary Completion Date

July 31, 2026

Study Completion Date

July 31, 2026

Conditions
Glioma
Trial Locations (7)

10065

RECRUITING

Memorial Sloan Kettering Cancer Center (All Protocol Activities), New York

10604

RECRUITING

Memorial Sloan Kettering West Harrison (All Protocol Activities), Harrison

11570

RECRUITING

Memorial Sloan Kettering Nassau (All Protocol Activities), Rockville Centre

11725

RECRUITING

Memorial Sloan Kettering Suffolk - Commack (All Protocol Activities), Commack

07920

RECRUITING

Memorial Sloan Kettering Basking Ridge (All Protocol Activities), Basking Ridge

07748

RECRUITING

Memorial Sloan Kettering Monmouth (All protocol activities), Middletown

07645

RECRUITING

Memorial Sloan Kettering Bergen (All Protocol Activities), Montvale

All Listed Sponsors
lead

Memorial Sloan Kettering Cancer Center

OTHER